Body image and quality of life in men with prostate cancer

Cancer Nursing

Volumn 32, Issue 2, 2009, Pages

  Harrington, Joanne M ^b   Badger, Terry A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b Phoenix Veterans Affairs Health Care System   (United States)

Author keywords

Androgen deprivation therapy; Body image; Prostate cancer; Quality of life

Indexed keywords

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BODY IMAGE; BODY IMAGE SCALE; CANCER SURVIVOR; EVIDENCE BASED PRACTICE; HOSPITAL DEPARTMENT; HUMAN; INFERENTIAL STATISTICS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; QUALITY OF LIFE INDEX CANCER VERSION; QUESTIONNAIRE; SCORING SYSTEM; UROLOGY;

AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; BODY IMAGE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SURVIVORS;

EID: 68149124329     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/NCC.0b013e3181982d18     Document Type: Article

References (40)

1. Jemal A, Seigel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71-96.
2. Michaelson MD, Cotter SE, Gargollo PC, Zeitman AL, Dahl DM, Smith MR. Complications of prostate cancer treatment. CA Cancer J Clin. 2008;58(4):196-213.
3. Williams MB, Hernandez J, Thompson I. Luteinizing hormone-releasing hormone agonist effects on skeletal muscle: how hormonal therapy in prostate cancer affects muscular strength. J Urol. 2005;173:1067-1071. (Pubitemid 40380505)
4. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003;8:474-487.
5. O'Connor KM, Fitzpatrick JM. Side-effects of treatments for locally advanced prostate cancer. BJU Int. 2005;97:22-28.
6. American Cancer Society. Overview: prostate cancer how is prostate cancer treated? http://www.cancer.org/docroot/CRI/content/CRI- 2-2-4X-How-Is-Prostate- Cancer-Treated-36.asp?rnav=cri. Accessed August 4, 2008.
7. Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology. 2003;61(suppl 2A):32-38.
8. Avis N, Crawford S, Manuel J. Quality of life among younger women with breast cancer. J Clin Oncol. 2005;23(15):3322-3330. (Pubitemid 46243476)
9. Ganz PA, Kwan L, Stanton AL, et al. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst. 2004;96(5):376-387. (Pubitemid 38351299)
10. Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol. 2003;21(22):4184-4193. (Pubitemid 46606187)
11. Pruzinsky T, Cash TF. Assessing body image and quality of life in medical settings. In: Pruzinsky T, Cash TF, eds. Body Image. New York, NY: The Guilford Press; 2002:171-179.
12. Shahinian VB, Kuo Y-F, Freeman JL, Orihuela E, Goodwin JS. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer. 2006;103(8):1615-1624.
13. Ferrans C. Development of a conceptual model of quality of life. Sch Inq Nurs Pract. 1996;10(3):293-304.
14. Kornblith AB, Herr HW, Ofman US, Scher HI, Holland JC. Quality of life of patients with prostate cancer and their spouses. Cancer. 1994; 73(11):2791-2802.
15. Herr HW. Quality of life in prostate cancer. CA Cancer J Clin. 1997; 7(47):207-217.
16. Eton DT, Lepore SJ. Prostate cancer and health-related quality of life: a review of the literature. Psychooncology. 2002;11:307-326. (Pubitemid 34987589)
17. Weber BA, Sherwill-Navarro P. Psychosocial consequences of prostate cancer: 30 years of research. Geriatr Nurs. 2005;26(3):166-175. (Pubitemid 40867731)
18. Galbraith ME, Arechiga A, Ramirez J, Pedro LW. Prostate cancer survivors' and partners' self-reports of health-related quality of life, treatment symptoms, and marital satisfaction 2.5Y5.5 years after treatment. Oncol Nurs Forum. 2005;32:E30-E41. http://ons.metapress.com/content/ t128147q6u1684t8/?p= 1ea01ba370974b12a7fe1ee0506be816&pi=0. Accessed March 30, 2007.
19. Dacal K, Sereika SM, Greenspan SL. Quality of life in prostate cancer patients taking androgen deprivation therapy. JAGS. 2006;54(1):85-90.
20. Miller DC, Sanda MG, Dunn RL, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23(12):2772-2780.
21. Potosky AL, Davis WW, Hoffman RM, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst. 2004;96(18):1358-1367. (Pubitemid 39406169)
22. Andel GV, Kurth KH. The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer. Eur Urol. 2003;44:209-214.
23. Herr HW, O'Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol. 2000;163:1743-1746. (Pubitemid 30366726)
24. Lubeck DP, Grossfeld GD, Carroll PR. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer. Urology. 2001;58(suppl 2A):94-99. (Pubitemid 32743420)
25. Potosky AL, Reeve BB, Clegg LX, et al. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst. 2002;94(6):430-437. (Pubitemid 34285092)
26. Moinpour CM, Savage MJ, Troxel A, et al. Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. J Natl Cancer Inst Monogr. 1998;90(20):1537-1544. (Pubitemid 28535718)
27. Green HJ, Pakenham KI, Headley BC, et al. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int. 2004; 93:975-979. (Pubitemid 38758617)
28. McPherson CP, Swenson KK, Kjellberg J. Quality of life in patients with prostate cancer. Semin Oncol Nurs. 2001;17(2):138-146.
29. Clark JA, Wray N, Brody B, Ashton C, Geisler B, Watkins H. Dimensions of quality of life expressed by men treated for metastatic prostate cancer. Soc Sci Med. 1997;45(8):1299-1309. (Pubitemid 27387167)
30. Harrington JM, Jones EG, Badger TA. Body image perceptions among men with prostate cancer. Oncol Nurs Forum. In press.
31. Hopwood P, Fletcher I, Lee A, Ghazal SA. A Body Image Scale for use with cancer patients. Eur J Cancer. 2001;37:189-197. (Pubitemid 32144695)
32. Fowler FJ, Collins MM, Corkery EW, Elliott DB, Barry MJ. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate cancer. Cancer. 2002;95:287-295. (Pubitemid 34787594)
33. King CR. Overview of quality of life and controversial issues. In: King CR, Hinds PS, eds. Quality of Life From Nursing and Patient Perspectives. Boston, MA: Jones and Bartlett Publishers; 2003:29-42.
34. Herr HW, O'Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol. 2000;163:1743-1746. (Pubitemid 30366726)
35. Basaria S, Lieb JI, Tang AM, et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol. 2002; 56:779-786. (Pubitemid 34785910)
36. Pinto BM, Trunzo JJ. Body esteem and mood among sedentary and active breast cancer survivors. Mayo Clin Proc. 2004;79:181-186. (Pubitemid 38140802)
37. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21:1653-1659. (Pubitemid 46638574)
38. Navon L, Morag A. Advanced prostate cancer patients' relationships with their spouses following hormonal therapy. Eur J Oncol Nurs. 2003; 7(2):73-80. (Pubitemid 36747877)
39. Harden J, Schafenacker A, Northouse L, et al. Couples' experiences with prostate cancer: focus group research. Oncol Nurs Forum. 2002;29(4): 701-709.
40. Couper J, Bloch S, Love A, Macvean M, Duchesne GM, Kissane D. Psychosocial adjustment of female partners of men with prostate cancer: a review of the literature. Psychooncology. 2006;15:937-953. (Pubitemid 44762700)